Furthermore, there is supporting evidence that compensatory hyperinsulinemia and insulin-like growth factor (IGF) in obesity may promote the development of HCC by activating various oncogenic pathways [1]. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.